The Canadian icon is the latest in a long line of celebrities under the Canopy Growth umbrella – but what does he know about cannabis?

The continent’s famously liberal attitude toward weed is not paralleled by a political tolerance for it

If declining stocks can cost the head of one of the few bright spots in the industry his job, where does that leave the rest of the business of bud?

Among the most painful is taxane-induced peripheral neuropathy, a condition that affects more than 67 per cent of women undergoing breast cancer treatment

The Ontario government is citing rising use among young people for the move

His plan includes $20-billion to set up a Minority Business Development Agency to provide grants to entrepreneurs of colour